| Year |
Citation |
Score |
| 2014 |
Sahu RP, Ocana JA, Harrison KA, Ferracini M, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK, Perkins SM, Speicher PJ, Tyler DS, Konger RL, Travers JB. Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor. Cancer Research. 74: 7069-78. PMID 25304264 DOI: 10.1158/0008-5472.Can-14-2043 |
0.334 |
|
| 2013 |
Lakhter AJ, Kanginakudru S, Warren S, Touloukian CE, Boissy RE, Naidu SR. Impaired PIASy-Tip60 signaling weakens activation of p53 in melanoma. Melanoma Research. 23: 213-7. PMID 23624367 DOI: 10.1097/Cmr.0B013E328361056D |
0.303 |
|
| 2012 |
Sahu RP, Turner MJ, DaSilva SC, Rashid BM, Ocana JA, Perkins SM, Konger RL, Touloukian CE, Kaplan MH, Travers JB. The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. Carcinogenesis. 33: 1360-7. PMID 22542595 DOI: 10.1093/Carcin/Bgs152 |
0.441 |
|
| 2012 |
Sahu RP, Konger RL, Touloukian CE, Travers JB. Abstract 1548: Ultraviolet B-induced platelet-activating factor receptor agonists mediate augmentation of melanoma tumor growth via regulatory T cells: Implication of systemic immunosuppression Cancer Research. 72: 1548-1548. DOI: 10.1158/1538-7445.Am2012-1548 |
0.466 |
|
| 2010 |
Ha SP, Klemen ND, Kinnebrew GH, Brandmaier AG, Marsh J, Hangoc G, Palmer DC, Restifo NP, Cornetta K, Broxmeyer HE, Touloukian CE. Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity. The Journal of Clinical Investigation. 120: 4273-88. PMID 21084750 DOI: 10.1172/Jci43274 |
0.598 |
|
| 2009 |
Brandmaier AG, Leitner WW, Ha SP, Sidney J, Restifo NP, Touloukian CE. High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction. Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 677-88. PMID 19561540 DOI: 10.1097/Cji.0B013E3181Ab1824 |
0.602 |
|
| 2008 |
Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, Paulos CM, Palmer DC, Touloukian CE, Ptak K, Gattinoni L, Wrzesinski C, Hinrichs CS, Kerstann KW, Feigenbaum L, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 112: 362-73. PMID 18354038 DOI: 10.1182/Blood-2007-11-120998 |
0.485 |
|
| 2008 |
Brandmaier AG, Touloukian CE. 71. TRP-1−/− Mice Vaccinated With TRP-1 Generate High Avidity T-Cells That are Protective Against Melanoma Journal of Surgical Research. 144: 207-208. DOI: 10.1016/J.Jss.2007.12.081 |
0.557 |
|
| 2004 |
Yu Z, Theoret MR, Touloukian CE, Surman DR, Garman SC, Feigenbaum L, Baxter TK, Baker BM, Restifo NP. Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance. The Journal of Clinical Investigation. 114: 551-9. PMID 15314692 DOI: 10.1172/Jci21695 |
0.449 |
|
| 2003 |
Phan GQ, Touloukian CE, Yang JC, Restifo NP, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, White DE, Rosenberg SA. Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens. Journal of Immunotherapy (Hagerstown, Md. : 1997). 26: 349-56. PMID 12843797 DOI: 10.1097/00002371-200307000-00007 |
0.422 |
|
| 2003 |
Touloukian CE, Leitner WW, Schnur RE, Robbins PF, Li Y, Southwood S, Sette A, Rosenberg SA, Restifo NP. Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1. Journal of Immunology (Baltimore, Md. : 1950). 170: 1579-85. PMID 12538723 DOI: 10.4049/Jimmunol.170.3.1579 |
0.363 |
|
| 2002 |
Sloan JM, Kershaw MH, Touloukian CE, Lapointe R, Robbins PF, Restifo NP, Hwu P. MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells. Cancer Gene Therapy. 9: 946-50. PMID 12386833 DOI: 10.1038/Sj.Cgt.7700509 |
0.437 |
|
| 2002 |
Touloukian CE, Leitner WW, Robbins PF, Li YF, Kang X, Lapointe R, Hwu P, Rosenberg SA, Restifo NP. Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function. Cancer Research. 62: 5144-7. PMID 12234976 |
0.546 |
|
| Show low-probability matches. |